NCT01313442 Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer
| NCT ID | NCT01313442 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Cancer Institute (NCI) |
| Condition | Non-GI Cancers |
| Study Type | OBSERVATIONAL |
| Enrollment | 550 participants |
| Start Date | 2011-03-02 |
| Primary Completion | — |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 550 participants in total. It began in 2011-03-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Background: \- Gastrointestinal cancers can occur in the throat, stomach, gallbladder, liver, pancreas, and colon. Researchers are interested in evaluating how active the immune system is in trying to fight the cancer by studying blood and tumor tissue donated from individuals who have been diagnosed with gastrointestinal cancers. Objectives: \- To collect blood and tumor samples from individuals who have been diagnosed with gastrointestinal cancers in order to study the immune system s response to the cancer. Eligibility: \- Individuals at least 18 years of age who have been diagnosed with throat, stomach, gallbladder, liver, pancreatic, or colon cancer, and are scheduled to be treated at the National Institutes of Health. Design: * The study will require at least one but no more than four visits to the National Institutes of Health Clinical Center. * Participants will be screened with a physical examination and medical history, and will provide a baseline blood sample for study. * Participants will provide additional blood samples 2 and 4 months after the baseline sample, as well as a final sample at the completion of the treatment protocol. * Participants will provide tumor tissue samples only if they undergo a surgical procedure related to the treatment for their gastrointestinal cancer. * No treatment will be provided as part of this protocol.
Eligibility Criteria
* INCLUSION CRITERIA: * Individuals 18 years of age and older * Individuals with a diagnosis of cancer * Individuals must be able to understand and willing to sign a written informed consent document EXCLUSION CRITERIA: -None
Contact & Investigator
Tim F Greten, M.D.
PRINCIPAL INVESTIGATOR
National Cancer Institute (NCI)
Frequently Asked Questions
Who can join the NCT01313442 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-GI Cancers. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01313442 currently recruiting?
Yes, NCT01313442 is actively recruiting participants. Contact the research team at hickssn2@nih.gov for enrollment information.
Where is the NCT01313442 trial being conducted?
This trial is being conducted at Bethesda, United States.
Who is sponsoring the NCT01313442 clinical trial?
NCT01313442 is sponsored by National Cancer Institute (NCI). The principal investigator is Tim F Greten, M.D. at National Cancer Institute (NCI). The trial plans to enroll 550 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.